![]() GSK-2793660 structure
|
Common Name | GSK-2793660 | ||
---|---|---|---|---|
CAS Number | 1613458-70-0 | Molecular Weight | 357.45 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H27N3O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of GSK-2793660GSK-2793660 is an oral, irreversible inhibitor of Cathepsin C (CTSC). GSK-2793660 can be used for the research of bronchiectasis[1][2]. |
Name | GSK-2793660 |
---|
Description | GSK-2793660 is an oral, irreversible inhibitor of Cathepsin C (CTSC). GSK-2793660 can be used for the research of bronchiectasis[1][2]. |
---|---|
Related Catalog | |
Target |
Cathepsin C (CTSC)[1][2] |
In Vivo | GSK-2793660 is a cathepsin C (also known as dipeptidyl peptidase I enzyme) inhibitor for the reaearch of cystic fibrosis, non-cystic fibrosis bronchiectasis, anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and bronchiectasis[1]. |
References |
Molecular Formula | C20H27N3O3 |
---|---|
Molecular Weight | 357.45 |